Aion Therapeutic Inc.
ANTCF
$0.012
-$0.003-20.00%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.19M | -1.07M | -1.37M | -547.20K | -1.29M |
| Total Depreciation and Amortization | 11.20K | 4.40K | 8.80K | 13.10K | 14.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 557.60K | 452.20K | 835.80K | -75.70K | 261.60K |
| Change in Net Operating Assets | 708.70K | 431.90K | 446.20K | 575.80K | 878.20K |
| Cash from Operations | 84.50K | -184.60K | -75.70K | -34.10K | -136.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 100.30K | 100.30K | 100.30K | 100.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -215.00K | -197.70K | -99.70K | -- | -- |
| Cash from Investing | -215.00K | -97.40K | 600.00 | 100.30K | 152.20K |
| Total Debt Issued | 36.00K | 19.40K | 98.60K | 237.60K | 308.10K |
| Total Debt Repaid | -12.30K | -141.80K | -148.20K | -174.40K | -174.30K |
| Issuance of Common Stock | 542.60K | 542.60K | 371.30K | 100.00K | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.90K | -- | -- | -- | 0.00 |
| Cash from Financing | 439.70K | 312.10K | 242.30K | 126.70K | 182.50K |
| Foreign Exchange rate Adjustments | -50.60K | -39.70K | -179.50K | -192.30K | -147.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 258.60K | -9.40K | -12.20K | 800.00 | -900.00 |
